Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017385 220014353 1.81 null null 2014-11-26 2014-11-27 Rituximab N N 220030395 RITUXIMAB
220017387 220007942 1.57 78.6 null 2014-02-18 2014-02-18 Dasatinib N Y 220030429 DASATINIB
220017388 220007943 0 68.9 null 2016-09-24 2016-09-24 Dasatinib 2 N 220030431 DASATINIB
220017389 220017833 1.49 69.4 Palliative (P) null 2017-09-15 AML 18 TRIAL 01 N 220030435 AML18 TRIAL
220017390 220007951 1.74 null Curative (C) 2013-08-24 2014-01-10 Dasatinib N N 220030438 DASATINIB
220017391 220007954 null 69 Curative (C) 2015-10-21 2015-10-21 Dasatinib 99 N 220030445 DASATINIB
220017392 220007954 null 67.3 Curative (C) 2016-09-17 2016-09-21 AML 18 TRIAL N null 220030445 AML18 TRIAL
220017393 220007956 1.88 null Palliative (P) 2017-04-26 2017-04-29 Dasatinib N null 220030458 DASATINIB
220017394 220007957 null null null 2016-07-31 2016-08-05 Dasatinib 02 N 220030460 DASATINIB
220017395 220007958 0 83 Disease modification (D) 2015-09-17 2015-10-01 Rituximab N null 220030463 RITUXIMAB
220017396 220007959 1.7 72 Curative (C) 2013-10-05 2013-10-05 AML18 PILOT TRIAL Y N 220030466 PILOT TRIAL
220017397 220007959 1.76 0 Curative (C) 2015-01-02 2015-02-12 Dasatinib N N 220030466 DASATINIB
220017398 220007963 1.79 56.5 Curative (C) 2018-02-01 2018-02-13 Alemtuz+Fludara+Melphalan RIC MUD N null 220030475 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017399 220007968 1.66 null null 2017-06-20 2017-06-27 Dasatinib N N 220030478 DASATINIB
220017401 220007976 0 81.6 Curative (C) 2018-04-23 2018-04-23 AML18 PILOT TRIAL null N 220030494 PILOT TRIAL
220017402 220007977 1.9 62.8 Curative (C) 2014-09-09 2014-09-09 AML 18 TRIAL N N 220030495 AML18 TRIAL
220017403 220014377 null 47.8 Disease modification (D) 2014-01-21 2014-01-22 Rituximab N N 220030497 RITUXIMAB
220017404 220007986 1.68 null Curative (C) 2015-09-08 2015-09-18 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220030515 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017405 220007987 1.58 67.2 Curative (C) null 2016-10-08 AML18 PILOT TRIAL 2 N 220030518 PILOT TRIAL
220017406 220007989 1.62 53.7 Curative (C) 2013-08-22 2013-08-22 Dasatinib N null 220030520 DASATINIB
220017407 220007991 1.67 54.6 Curative (C) 2013-08-12 2013-08-12 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220030524 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017408 220007995 null 70.6 null null 2014-12-25 AML18 PILOT TRIAL 1 N 220030530 PILOT TRIAL
220017409 220014385 1.6 63 Curative (C) 2017-12-10 2018-03-20 AML18 PILOT TRIAL N N 220030531 PILOT TRIAL
220017410 220007999 1.77 101.5 Curative (C) 2016-02-08 2016-03-08 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030535 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017411 220008003 1.94 84.9 null 2018-05-20 2018-05-24 Rituximab N N 220030537 RITUXIMAB
220017412 220008004 1.61 null Palliative (P) 2014-10-29 2015-08-02 Dasatinib N N 220030541 DASATINIB
220017413 220008007 1.57 0 Disease modification (D) 2014-06-01 2014-06-03 Dasatinib 2 N 220030541 DASATINIB
220017414 220008011 1.69 73 Disease modification (D) 2014-07-31 2014-10-29 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030561 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017415 220008015 1.62 57.5 Disease modification (D) 2017-08-29 2017-09-04 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220030565 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017416 220008019 1.58 89 Curative (C) 2015-03-01 2015-03-17 Alemtuz+Fludara+Melphalan RIC MUD N N 220030571 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017417 220008022 1.87 null Disease modification (D) 2014-09-30 2014-10-08 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030584 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017419 220008027 null 0 Palliative (P) 2016-04-02 2016-04-03 Dasatinib N null 220030597 DASATINIB
220017420 220014396 1.77 null Palliative (P) 2016-08-27 2016-08-27 Dasatinib 02 N 220030600 DASATINIB
220017421 220008030 null 97 Disease modification (D) 2016-04-25 2016-07-12 AML18 PILOT TRIAL Y N 220030624 PILOT TRIAL
220017422 220008034 1.6 82.2 Palliative (P) 2012-06-08 2014-12-20 Dasatinib 01 N 220030630 DASATINIB
220017423 220008040 0 48.6 Adjuvant (A) 2018-11-29 2018-12-02 Dasatinib 02 null 220030651 DASATINIB
220017424 220014402 null 95.2 Curative (C) 2018-01-03 2018-01-17 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 N 220030653 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017425 220008044 null 60.8 Curative (C) 2013-03-18 2013-05-01 AML18 PILOT TRIAL N null 220030661 PILOT TRIAL
220017426 220008047 1.64 91 Curative (C) 2017-04-19 2017-04-20 Dasatinib N N 220030664 DASATINIB
220017427 220008049 null 80.75 Curative (C) 2015-09-27 2015-12-07 AML 18 TRIAL Y null 220030685 AML18 TRIAL
220017428 220017861 1.78 63.4 Palliative (P) 2013-02-27 2013-04-15 AML 18 TRIAL N N 220030685 AML18 TRIAL
220017429 220008053 1.73 0 Palliative (P) 2014-03-04 2014-03-06 Dasatinib N N 220030693 DASATINIB
220017430 220008054 1.72 95.7 Curative (C) 2017-10-08 2017-10-08 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 N 220030694 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017431 220008055 1.9 79 Curative (C) 2017-08-07 2017-08-21 Alemtuz+Fludara+Melphalan RIC MUD N N 220030706 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017432 220008057 1.6 65 Curative (C) 2014-02-09 2014-02-17 Dasatinib N N 220030712 DASATINIB
220017433 220008059 1.6 80.5 Curative (C) 2017-09-19 2017-09-22 AML18 PILOT TRIAL N N 220030713 PILOT TRIAL
220017434 220008062 1.65 66.1 Disease modification (D) 2016-02-23 2016-02-25 RUXOLITINIB 02 N 220030719 RUXOLITINIB
220017435 220008064 1.56 0 Disease modification (D) 2018-01-16 2018-01-16 CYCLOPHOSPHAMIDE + FLUDARABINE 02 null 220030722 CYCLOPHOSPHAMIDE + FLUDARABINE
220017436 220008065 1.28 72.5 Curative (C) 2017-04-25 2017-04-25 FLAG 99 N 220030730 FLAG
220017437 220008068 null null Palliative (P) 2012-12-31 2013-05-16 RUXOLITINIB N N 220030733 RUXOLITINIB